Linezolid Tablet
Linezolid is available as an FDA-approved commercial product and as a compounded formulation, prepared by Mixlab for veterinary use in dogs and cats. Available by prescription.
The uses and pharmacology described below reflect the FDA-approved labeling for this active ingredient; your veterinarian determines whether and how they apply to your animal's treatment plan.
In humans, linezolid is FDA-approved for specific infections caused by susceptible gram-positive bacteria, including certain types of pneumonia, skin infections, and vancomycin-resistant Enterococcus faecium infections. In veterinary medicine, linezolid is reserved for a narrow set of circumstances: multidrug-resistant gram-positive infections in dogs and cats, confirmed by culture and susceptibility testing, where other antimicrobial options have been ruled out. It is not considered a routine or first-line antibiotic in animals.
At a pharmacological level, linezolid is a bacteriostatic oxazolidinone that works by binding to the bacterial 50S ribosomal subunit, preventing formation of the complex needed to initiate bacterial protein synthesis. This mechanism is distinct from other antibiotic classes, which is part of why it retains activity against some organisms that have become resistant to more commonly used antimicrobials.
Prescription only. Use only under the direction of a licensed veterinarian. This information is not a substitute for veterinary diagnosis, prescribing, or monitoring. Compounded drugs are not approved by the FDA for safety or effectiveness.
Linezolid is generally reserved for confirmed multidrug-resistant infections and is not used empirically; your veterinarian will typically base the decision to use it on culture and susceptibility results. Because it remains one of a limited number of effective options against certain resistant organisms of importance to human health, veterinarians take a conservative approach to its use, and some clinics require specific internal approval before it is prescribed.
With extended use, linezolid has been associated with myelosuppression (reduced blood cell counts, including platelets), so your veterinarian may recommend periodic bloodwork to monitor for this during treatment. Peripheral or optic neuropathy, including changes in vision, has also been reported with prolonged courses. Linezolid can interact seriously with certain other medications, including MAO inhibitors and drugs that affect serotonin levels, so it is essential to provide your veterinarian with a complete list of everything else your pet is taking. Commonly observed effects may include gastrointestinal changes such as vomiting, diarrhea, or decreased appetite. Contact your veterinarian promptly if you notice unusual bruising, bleeding, lethargy, or changes in your pet's vision or behavior during treatment.
Yes. Linezolid is a prescription medication and can only be dispensed by a licensed pharmacy upon receipt of a valid authorization from a licensed veterinarian. Mixlab verifies all prescriptions before any medication is prepared or shipped.
Both. Mixlab can dispense the FDA-approved commercial tablet or oral suspension, or compound the active ingredient into an alternative strength or format if your veterinarian determines that better suits your pet's needs. The decision between a commercial and compounded product rests with the prescribing veterinarian.
Veterinarians typically consider linezolid only after culture and susceptibility testing shows that an infection is resistant to more commonly used antimicrobials. Because linezolid remains effective against some of these resistant organisms, its use is generally reserved for these specific situations rather than used as a routine or first-choice antibiotic.
Depending on the length of treatment, your veterinarian may recommend periodic bloodwork to monitor blood cell counts, since extended use has been associated with effects on bone marrow function. Your veterinarian will let you know what monitoring is appropriate for your pet's specific treatment course.
